Dr. Eric Magda, MD

NPI: 1679960850
Total Payments
$4,060
2024 Payments
$531.14
Companies
17
Transactions
73
Medicare Patients
1,115
Medicare Billing
$78,056

Payment Breakdown by Category

Food & Beverage$3,073 (75.7%)
Travel$986.57 (24.3%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $3,073 69 75.7%
Travel and Lodging $986.57 4 24.3%

Top Paying Companies

Company Total Records Latest Year
Abbott Laboratories $1,642 12 $0 (2024)
Medtronic USA, Inc. $537.36 8 $0 (2020)
Boston Scientific Corporation $281.06 3 $0 (2023)
TerSera Therapeutics LLC $212.36 8 $0 (2024)
ABBVIE INC. $186.94 10 $0 (2024)
Valinor Pharma, LLC $172.98 5 $0 (2024)
Nevro Corp. $149.97 4 $0 (2023)
Nuvectra Corporation $148.71 1 $0 (2017)
Allergan Inc. $148.54 1 $0 (2017)
Teva Pharmaceuticals USA, Inc. $118.75 1 $0 (2020)

Payment History by Year

Year Amount Transactions Top Company
2024 $531.14 23 ABBVIE INC. ($151.26)
2023 $561.80 20 Boston Scientific Corporation ($140.54)
2022 $172.02 3 Boston Scientific Corporation ($126.73)
2021 $219.38 5 Abbott Laboratories ($144.17)
2020 $440.38 6 Medtronic USA, Inc. ($287.52)
2019 $1,838 14 Abbott Laboratories ($1,395)
2017 $297.25 2 Nuvectra Corporation ($148.71)

All Payment Transactions

73 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
12/10/2024 Medtronic, Inc. INTELLIS ADAPTIVESTIM (Device) Food and Beverage In-kind items and services $22.95 General
Category: Spinal Cord Neurostimulation
11/21/2024 Collegium Pharmaceutical, Inc. XTAMPZA (Drug) Food and Beverage Cash or cash equivalent $17.96 General
Category: Opioid Analgesic
11/20/2024 Abbott Laboratories PROCLAIM (Device) Food and Beverage In-kind items and services $17.99 General
Category: Neuromodulation
10/10/2024 SPR Therapeutics, Inc SPRINT PNS System (Device) Food and Beverage Cash or cash equivalent $15.96 General
Category: Pain management
09/11/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $22.77 General
Category: NEUROSCIENCE
09/10/2024 Valinor Pharma, LLC MOVANTIK (Drug) Food and Beverage In-kind items and services $27.34 General
Category: GASTROENTEROLOGY
08/28/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $15.60 General
Category: NEUROSCIENCE
07/25/2024 SCILEX PHARMACEUTICALS INC. ZTLido (Drug) Food and Beverage In-kind items and services $21.98 General
Category: Analgesic
07/18/2024 Abbott Laboratories OCTRODE (Device) Food and Beverage In-kind items and services $21.92 General
Category: Neuromodulation
07/16/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $27.33 General
Category: NEUROSCIENCE
07/02/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $18.08 General
Category: NEUROSCIENCE
06/26/2024 SCILEX PHARMACEUTICALS INC. ZTLido (Drug) Food and Beverage In-kind items and services $21.98 General
Category: Analgesic
05/29/2024 SPR Therapeutics, Inc SPRINT PNS System (Device) Food and Beverage Cash or cash equivalent $18.11 General
Category: Pain management
05/28/2024 Valinor Pharma, LLC MOVANTIK (Drug) Food and Beverage In-kind items and services $28.44 General
Category: GASTROENTEROLOGY
05/09/2024 TerSera Therapeutics LLC Prialt (Drug) Food and Beverage In-kind items and services $28.53 General
Category: Pain Management
05/02/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $25.05 General
Category: NEUROSCIENCE
04/16/2024 Valinor Pharma, LLC MOVANTIK (Drug) Food and Beverage In-kind items and services $58.00 General
Category: GASTROENTEROLOGY
03/12/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $20.00 General
Category: NEUROSCIENCE
03/07/2024 TerSera Therapeutics LLC Prialt (Drug) Food and Beverage In-kind items and services $28.08 General
Category: Pain Management
02/29/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $1.52 General
Category: NEUROSCIENCE
01/30/2024 Valinor Pharma, LLC MOVANTIK (Drug) Food and Beverage In-kind items and services $23.20 General
Category: GASTROENTEROLOGY
01/11/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $20.91 General
Category: NEUROSCIENCE
01/05/2024 TerSera Therapeutics LLC Prialt (Drug) Food and Beverage In-kind items and services $27.44 General
Category: Pain Management
12/07/2023 Collegium Pharmaceutical, Inc. XTAMPZA (Drug) Food and Beverage Cash or cash equivalent $15.13 General
Category: Opioid Analgesic
11/30/2023 Valinor Pharma, LLC MOVANTIK (Drug) Food and Beverage In-kind items and services $36.00 General
Category: Pain Management

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 15 565 675 $187,094 $38,442
2022 9 366 456 $116,999 $24,697
2021 8 184 221 $65,332 $14,918
Total Patients
1,115
Total Services
1,352
Medicare Billing
$78,056
Procedure Codes
40

All Medicare Procedures & Services

40 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 77 102 $19,176 $7,382 38.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2023 104 136 $17,681 $6,392 36.1%
62323 Injection of substance into lower spine canal using imaging guidance Facility 2023 51 65 $27,170 $4,754 17.5%
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2023 46 46 $13,708 $4,292 31.3%
G3002 Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan tha Facility 2023 44 45 $8,865 $2,533 28.6%
64493 Injection of lower or sacral spine facet joint using imaging guidance, single level Facility 2023 15 22 $9,950 $1,564 15.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 34 37 $4,736 $1,502 31.7%
27096 Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance Facility 2023 13 18 $23,880 $1,471 6.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 16 19 $3,572 $1,282 35.9%
00811 Anesthesia for other procedure on large bowel using an endoscope Facility 2023 21 21 $14,256 $1,171 8.2%
99203 New patient office or other outpatient visit, 30-44 minutes Facility 2023 18 18 $3,456 $1,091 31.6%
20610 Aspiration and/or injection of fluid from large joint Facility 2023 18 25 $5,568 $907.86 16.3%
62323 Injection of substance into lower spine canal using imaging guidance Office 2023 11 12 $5,016 $850.15 16.9%
00910 Anesthesia for other procedure on urinary system through urethra Facility 2023 15 16 $10,773 $759.00 7.0%
64494 Injection of lower or sacral spine facet joint using imaging guidance, second level Facility 2023 13 19 $3,914 $740.54 18.9%
00731 Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope Facility 2023 12 12 $8,586 $675.83 7.9%
20552 Injection of trigger points, 1-2 muscles Facility 2023 21 25 $3,050 $668.54 21.9%
96136 Administration of psychological or neuropsychological test, first 30 minutes Facility 2023 22 22 $2,222 $274.05 12.3%
96136 Administration of psychological or neuropsychological test, first 30 minutes Office 2023 14 15 $1,515 $133.20 8.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 47 88 $11,264 $4,219 37.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 44 49 $9,212 $3,627 39.4%
62323 Injection of substance into lower spine canal using imaging guidance Office 2022 25 41 $17,138 $2,937 17.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 25 38 $7,144 $2,675 37.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2022 43 50 $6,610 $2,576 39.0%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 29 29 $8,642 $2,528 29.3%

About Dr. Eric Magda, MD

Dr. Eric Magda, MD is a Anesthesiology healthcare provider based in Farrell, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/24/2015. The National Provider Identifier (NPI) number assigned to this provider is 1679960850.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Magda, MD has received a total of $4,060 in payments from pharmaceutical and medical device companies, with $531.14 received in 2024. These payments were reported across 73 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($3,073).

As a Medicare-enrolled provider, Magda has provided services to 1,115 Medicare beneficiaries, totaling 1,352 services with total Medicare billing of $78,056. Data is available for 3 years (2021–2023), covering 40 distinct procedure/service records.

Practice Information

  • Specialty Anesthesiology
  • Location Farrell, PA
  • Active Since 04/24/2015
  • Last Updated 03/30/2022
  • Taxonomy Code 207L00000X
  • Entity Type Individual
  • NPI Number 1679960850

Products in Payments

  • Proclaim Family of SCS IPGs (Device) $1,254
  • VECTRIS (Device) $307.20
  • Prialt (Drug) $212.36
  • ADAPTIVESTIM (Device) $184.16
  • MOVANTIK (Drug) $172.98
  • Algovita (Device) $148.71
  • VIBERZI (Drug) $148.54
  • Proclaim IPG (Device) $144.17
  • S-Series SCS Leads (Device) $132.89
  • General - Pain Management (Device) $126.73
  • QULIPTA (Drug) $123.93
  • AJOVY (Biological) $118.75
  • Trudhesa (Drug) $113.99
  • iFuse Implant (Device) $112.46
  • Senza Spinal Cord Stimulation System (Device) $100.40
  • PROCLAIM (Device) $80.83
  • ZTLido (Drug) $72.62
  • UBRELVY (Drug) $63.01
  • XTAMPZA (Drug) $60.46
  • RESTORE (Device) $46.00

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.